Filing Details

Accession Number:
0001209191-17-018049
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-03 19:25:26
Reporting Period:
2017-03-02
Filing Date:
2017-03-03
Accepted Time:
2017-03-03 19:25:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400971 L Bradley Campbell C/O Amicus Therapeutics, Inc.
1 Cedar Brook Drive
Cranbury NJ 08512
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-02 49,050 $8.00 127,475 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2016.